Page last updated: 2024-10-24

cefixime and Retrolental Fibroplasia

cefixime has been researched along with Retrolental Fibroplasia in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Research Excerpts

ExcerptRelevanceReference
"Ocular examination revealed orbital cellulitis."1.72A tale of orbital cellulitis and retinopathy of prematurity in an infant: First case report. ( Gurnani, B; Kannusamy, V; Kaur, K; Yadalla, D, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Kaur, K1
Gurnani, B1
Kannusamy, V1
Yadalla, D1

Other Studies

1 other study available for cefixime and Retrolental Fibroplasia

ArticleYear
A tale of orbital cellulitis and retinopathy of prematurity in an infant: First case report.
    European journal of ophthalmology, 2022, Volume: 32, Issue:6

    Topics: Cefixime; Child; Female; Gestational Age; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn;

2022